What question did this study set out to answer?

This study aims to evaluate the effects of combined EZH2 inhibition and dopamine D1 agonism on TNBC tumor progression and immune responses.

February 22, 2026Clinical Cancer Research

Abstract PS5-03-11: Combinatorial EZH2 Inhibition and Dopamine D1 Agonism Suppresses Pro-Inflammatory Monocytes and TNBC Tumor Progression

View Full Paper

Ask AI

Bookmark

Authors

RSRajni Kant ShuklaOklahoma State Department of Health KOKate OrmistonThe Ohio State University Wexner Medical Center GSGautam SarathyThe Ohio State University Wexner Medical Center

Discussion

Member takes

Implication

Experiment demonstrates decreased tumor growth and changes in immune cells in triple-negative breast cancer, implying potential for better treatment outcomes.

Key Points

This study aims to evaluate the effects of combined EZH2 inhibition and dopamine D1 agonism on TNBC tumor progression and immune responses.
Female NSG mice were injected with MDA-MB-231 TNBC cells.
Mice were divided into four treatment groups receiving different therapies.
Tumor size was monitored weekly and analyzed via calipers.
Post-treatment, tissues were harvested for flow cytometry analysis.
Combination therapy led to significant reduction in tumor weight (mean difference = 0.278 g, p = 0.0018) and volume (mean difference = 101 mm3, p < 0.0001).
A notable decrease in pro-inflammatory Ly6Chi monocyte infiltration by 65% was observed.
The combination increased anti-inflammatory Ly6Clo monocyte levels and showed trends of higher IL-10 and lower IL-1β production.

Cite This Study

Shukla et al. (2026) studied this question.

synapsesocial.com/papers/699a9dae482488d673cd3b29 https://doi.org/10.1158/1557-3265.sabcs25-ps5-03-11

View Full Paper

Ask AI

Bookmark

Implication

Experiment demonstrates decreased tumor growth and changes in immune cells in triple-negative breast cancer, implying potential for better treatment outcomes.

Abstract PS5-03-11: Combinatorial EZH2 Inhibition and Dopamine D1 Agonism Suppresses Pro-Inflammatory Monocytes and TNBC Tumor Progression

Discussion

Member takes

Implication

Key Points

Cite This Study

Abstract PS5-03-11: Combinatorial EZH2 Inhibition and Dopamine D1 Agonism Suppresses Pro-Inflammatory Monocytes and TNBC Tumor Progression

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider